Abstract
Radiotherapy has been used as an adjunct to surgical intervention for the last five decades, in view of documented effect on local control and reduced rates of vaginal vault recurrences. As surgical staging became established as part of the initial approach, a reassessment of the role of radiation in well-staged patients with low and intermediate risks of recurrence is ongoing. Intracavitary brachytherapy has low morbidity and is often used to reduce vaginal vault recurrences. External beam radiotherapy, on the other hand, achieves local control at the cost of some morbidity, and its impact on survival is uncertain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Thun, M.J. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66.
Stander, R.W. Vaginal metastastases following treatment of endometrial carcinoma. Am J Obstet Gynecol. 1956;71:776–9.
Price, J.J., Hahn, G.A., Rominger, C.J. Vaginal Involvement in Endometrial Carcinoma. Am J Obstet Gynecol. 1965;91:1060–5.
Creutzberg, C.L., van Putten, W.l., Koper, P.C., Lybeert, M.L., Jobsen, J.J., Warlam-Rodenhuis, C.C., et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404–11.
Keys, H.M., Roberts, J.A., Brunetto, V.L., Zaino, R.J., Spirtos, N.M., Bloss, J.D., et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744–51.
Nag, S., Yacoub, S., Copeland, L.J., Fowler, J.M. Interstitial brachtherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients. Int J Radiat Oncol Biol Phys. 2002;54:1153–9.
Jereczek-Fossa, B., Badzio, A., Jassem, J. Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:405–13.
Petignat, P., Jolocoeur, M., Alobaid, A., Drouin, P., Gauthier, P., Provencher, D., et al. Salvage treatment with high-dose-rate brachytherapy for isolated veginal endometrial cancer recurrence. Gynecol Oncol. 2006;101:445–9.
Huh, W.K., Straughn, J.M., Jr., Mariani, A., Podratz, K.C., Havrilesky, L.J., Alvarez-Secord, A., et al. Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gyenecol Cancer. 2007;17:886–9.
Creasman, W.T., Morrow, C.P., Bundy, B.N., Homesley, H.D., Graham, J.E., Heller, P.B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035–41.
Ben-Shacher, I., Pavelka, J., Cohn, D.E., Copeland, L.J., Ramirez, N., Manolotsas, T., et al. Surgical staging for patients presenting presenting with grade 1 endometrial carcinoma. Obstetrics and gynecology. 2005;105:487–93.
Mariani, A., Webb, M.J., Keeney, G.L., Haddock, M.G., Calori, G., Podratz, K.C. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506–19.
Creasman, W.T., DeGeest, K., DiSaia, P.J., Zaino, R.J. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1999;181:31–4.
Straughn, J.M., Jr., Huh, W.K., Kelly, F.J., Leath, C.A., 3rd, Kleinberg, M.J., Hyde, J., Jr., et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol. 2002;84:194–200.
Shumsky, A.G., Brasher, P.M., Stuart, G.C., Nation, J.G. Risk-specific follow-up for endometrial carcinoma patients. Gynecol Oncol. 1997;65:379–82.
DiSaia, P.J., Creasman, W.T., Boronow, R.C., Blessing, J.A. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985;151:1009–15.
Kilgore, L.C., Partidge, E.E., Alvarez, R.D., Austin, J.M., Shingleton, H.M., Noojin, F., 3rd, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvicnode sampling. Gynecol Oncol. 1995;56:29–33.
Carey, M.S., O’Connell, G.J., Johansson, C.R., Goodyear, M.D., Murphy, K.J., Daya, D.M., et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 1995;57:138–44.
Elliott, P., Green, D., Coates, A., Krieger, M., Russell, P., Coppleson, M., et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer. 1994;4:84–93.
Straughn, I.M., Huh, W.K., Orr, J.W., Jr., Kell, F.J., Roland, P.Y., Gold, M.A., et al. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol. 2003;89:295–300.
Lee, C.M., Szabo, A., Shrieve, D.C., Macdonald, O.K., Gaffney, D.K. Frequency and effect of adjuvant radiation therapy among women with stage | endometrial adenocarcinoma. Jama. 2006;295:389–97.
Straughn, J.M., Jr., Numnum, T.M., Kilgore, L.C., Partridge, E.E., Phillips, J.L., Markman, M., et al. The use of adjuvant radiation therapy in patients with intermediate-risk Stages IC and II uterine corpus cancer: a patient care evaluation study from the American College of Surgeons National Cancer Data Base. Gynecol Oncol. 2005;99:530–5.
Macdonald, O.K., Sause, W.T., Lee, R.J., Lee, C.M., Dodson, M.K., Zempolich, K., et al. Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecol Oncol. 2006;103:661–6.
Irwin, C., Levin, W., Fyles, A., Pintilie, M., Manchul, L., Kirkbride, P. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol. 1998;70:247–54.
Greven, K.M., Corn, B.W., Case, D., Purser, P., Lanciano, R.M. Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation? Int J Radiat Oncol Biol Phys. 1997;39:413–8.
Calvin, D.P., Connell, P.P., Rotmensch, J., Waggoner, S., Mundt, A.J. Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999;22:338–43.
Aalders, J., Abeler, V., Kolstad, P., Onsrud, M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstetrics and gynecology. 1980;56:419–27.
Piver, M.S., Hempling, R.E. A prospective trial of postoperative vaginal radium/cesium for grade 1–2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma. Cancer. 1990;66:1133–8.
Chadha, M., Nanavati, P.J., Liu, P., Fanning, J., Jacobs, A. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy. Gynecol Oncol. 1999;75:103–7.
Chong, I.Y., Hoskin, P.J. Vaginal vault brachytherapy for low risk endometrial carcinoma. Clin Oncol (R Coll Radiol). 2007;19:S8.
Eltabbakh, G.H., Piver, M.S., Hempling, R.E., Shin, K.H. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trail. Int J Radiat Oncol Biol Phys. 1997;38:373–80.
Alektiar, K.M., Venkatraman, E., Chi, D.S., Barakat, R.R. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys. 2005;62:111–7.
Pearcey, R.G., Petereit, D.G. Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer. Radiother Oncol. 2000;56:17–22.
Orton, C.G. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys. 2001;49:183–9.
Fayed, A., Mutch, D.G., Rader, J.S., Gibb, R.K., Powell, M.A., Wright, J.D., et al. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2007;67:480–4.
Bekerus, M., Durbaba, M., Frim, O., Vujnic, V. comparison of HDR and LDR results in endometrium cancer. Sonderb Strahlenther Onkol. 1988;82:222–7.
Rauthe, G., Vahrson, H., Giers, G. Five-year results and complications in endometrium cancer: HDR afterloading vs. conventional radium therapy. Sonderb Strahlenther Onkol. 1988;82:240–5.
Small, W., Jr., Erickson, B., Kwakwa, F. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int J Radiat Oncol Biol Phys. 2005;63:1502–7.
Nag, S., Erickson, B., Thomadsen, B., Orton, C., Demanes, J.D., Petereit, D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2000;48:201–11.
Houdek, P.V., Schwade, J.G., Abitbol, A.A., Pisciotta, V., Wu, X.D., Serago, C.F., et al. Optimization of high dose-rate cervix brachytherapy; Part I: Dose distribution. Int J Radiat Oncol Biol Phys. 1991;21:1621–5.
Maruyama, Y., Ezzell, G., Porter, A.T. Afterloading high dose rate intracavitary vaginal cylinder. Int J Radiat Oncol Biol Phys. 1994;30:473–6.
Demanes, D.J., Rege, S., Rodriquez, R.R., Schutz, K.L., Altieri, G.A., Wong, T. The use and advantages of a multichannel vaginal cyclinder in high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;44:211–9.
Corn, B.W., Lanciano, R.M., Greven, K.M., Noumoff, J., Schultz, D., Hanks, G.E., et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol. 1994;12:510–5.
Algan, O., Tabesh, T., Hanlon, A., Hogan, W.M., Boente, M., Lanciano, R.M. Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer. Int J Radiat Oncol Biol Phys. 1996;35:925–33.
Creutzberg, C.L., van Putten, W.L., Koper, P.C., Lybeert, M.L., Jobsen, J.J., Warlam-Rodenhuis, C.C., et al. The morbidity of treatment for patients with Stage I endometrial cancer; results from a randomized trial. Int J Radiat Oncol Biol Phys. 2001;51:1246–55.
Horowitz, N.S., Peters, W.A., 3rd, Smith, M.R., Drescher, C.W., Atwood, M., Mate, T.P. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endomentrial carcinoma. Obstetrics and gynecology. 2002;99:235–40.
Alektiar, K.M., McKee, A., Venkatraman, E., Mckee, B., Zelefsky, M.J., Mychalczak, B.R., et al. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer. Int J Radiat Oncol Biol Phys. 2002;53:707–13.
Petereit, D.G., Tannehill, S.P., Grosen, E.A., Hartenbach, E.M., Schink, J.C. Outpatient vaginal cuff brachytherapy for endometrial cancer. Int J Gynecol Cancer. 1999;9:456–62.
Sorbe, B.G., Smeds, A.C. Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I. Int J Radiat Oncol Biol Phys. 1990;18:305–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Baer, L., Wernicke, A.G., Formenti, S. (2009). Early-Stage Endometrial Cancer. In: Oliva, E., Muggia, F. (eds) Uterine Cancer. Current Clinical Oncology. Humana Press. https://doi.org/10.1007/978-1-60327-044-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-60327-044-1_9
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-736-5
Online ISBN: 978-1-60327-044-1
eBook Packages: MedicineMedicine (R0)